Proteasome inhibitors have been used to demonstrate that many proteins of the signal transduction pathways are regulated by degradation via the ubiquitin-proteasome pathway. The key question is what events target speci®c proteins for ubiquitination at one time and prevent ubiquitination at other times? In this review, we develop the notion that there is a direct relationship between the phosphorylation/dephosphorylation cascade of the signal transduction pathways and the targeting of the regulatory proteins for ubiquitination. We present examples where phosphorylation appears to alter the interaction between the targeting systems and the substrate by modifying the targeting system, the substrate, or both. These interacting systems are seen in the response of p53, c-jun and ATF-2 in cells subjected to stress or DNA damage and to the normal regulated response in a variety of pathways including the IkBNFkB and JAK-STAT pathways. The interweaving of the two post-translational networks, phosphorylation and ubiquitination, provides a powerful insight into global regulatory control pathways.
Introduction
The ubiquitin-proteasome pathway has been implicated in the degradation of a variety of dierent proteins in vitro, but it was not until the availability of speci®c proteasome inhibitors that could be used in living cells did it become apparent that this system was responsible for the degradation of speci®c proteins as part of normal cellular regulatory pathways. The covalent attachment of ubiquitin to the e-amino group of protein is a speci®c process involving a speci®c set of ubiquitin ligating enzymes. The multiubiquitination of protein, by sequential addition of ubiquitins to form a polymer, can target the protein to a multicatalytic proteasome complex, the 26S proteasome, where the protein is rapidly degraded . ATPand ubiquitin-dependent proteolysis by the 26S proteasome pathway determines protein availability and thus, both the magnitude and duration of a protein's ability to mediate respective cellular functions Hochstrasser, 1996) . Although the proteolysis process is not always constitutive and can be regulated by a variety of extra-and intracellular signals (Hochstrasser, 1995) , targeting proteins for ubiquitination is a dynamic process that is necessary for regulating protein stability (Isaksson et al., 1996) . The key to regulating proteins by the ubiquitinproteasome pathway is the selectivity of the ubiquitin targeting event. Great insight into this process has come from understanding the mechanism of cyclin regulation. These studies, recently reviewed (Chun et al., 1996) , indicate that selectivity is determined by the properties of the ubiquitinating enzyme that recognizes the speci®c protein substrate and the proper availability of the substrate protein itself. Our studies on the mechanisms of how cells respond to stress signals have provided further insight into ubiquitin targeting mechanisms.
The mechanisms that modulate ubiquitination by stress signals are: association with ancillary proteins, phosphorylation by speci®c kinases, and a combination of the two. Therefore, changes in ubiquitination would depend on the conformation of a speci®c substrate and its associated proteins.
Ubiquitination-dependent degradation has been shown to participate in regulating several stressactivated transcription factors (Isaksson et al., 1996; Brown and Pagano, 1997) . Cellular response to stress and damage, as well as mitogenic stimuli, initiates signal transduction cascades that modify the duration and magnitude of transcriptional activity of stress-responsive and mitogen-regulated transcription factors. The resulting changes in gene expression are implicated in cell proliferation or in programmed cell death.
Among stress-responsive kinases are Jun NH 2 -kinase (JNK), mitogen-activated protein kinase (MAPK), Janus kinase (JAK), protein kinase C (PKC), phosphatidylinositol 3 kinase (PI3K), DNA protein kinase (DNA-PK) and IkB kinases. These kinases regulate a dierent subset of substrates by acquiring a speci®c phosphorylation pattern that aects conformation, stability, subcellular localization and transcriptional activation. This review focuses on the contribution of stress-activated protein kinases to the regulation of protein targeting for ubiquitination after cellular exposure to stress and DNA damage.
Stress-activated kinases ± JNK
Stress-activated protein kinases (also called jun NH 2 kinases; JNK) are represented by more than ten dierent isozymes encoded by three genes (JNK1-3; Kyriakis and Avruch 1996) . Stress stimuli do not aect JNK expression but rather activate existing JNK molecules through phosphorylation by upstream kinases and inactivation of associated inhibitors. First, JNK activity as a kinase requires its phosphorylation on aa 183 and 185 by the upstream kinase MKK4 (JNKK or SEK1; Lin et al., 1994) . After stress, MKK4 itself is phosphorylated by its upstream kinase, MEKK1 (Yan et al., 1994 ). MEKK1's phosphorylation and its proteolytic activation by caspase 3 are alternate pathways involved in its regulation and subsequent activation of MKK4 and JNK (Deak et al., 1998) . Independently, in normal growing nonstressed cells, JNK activity as a kinase is inhibited by a redox-sensitive inhibitor that is inactivated by UVirradiation or an increase of oxygen radicals (Adler et al., unpublished observations) . JNK activity is also inhibited by its associated protein JIP, which contributes to the cytoplasmic retention of this kinase (Dickens et al., 1997) . Activation of JNK by alternate forms of stress uses dierent cellular pathways, suggesting that various stimuli could aect alternate cellular targets, which independently contribute to JNK activity. For example, heat shock activation of JNK requires no changes at the membrane level, whereas, UV-C (254 nm) irradiation requires proper membrane organization and the presence of nuclear DNA lesions (Adler et al., 1995a, b) . Similarly, dierent cellular components are involved in the activation of JNK by UV-C vs UV-B (300 nm). While UV-B mediates a weak (yet prolonged) activation of JNK (resembling JNK activation by TNF; Westwick et al., 1995) , UV-C causes a strong (yet brief) activation of this kinase (Adler et al., 1996) .
Unlike most kinases, JNK is tightly bound to its substrates, c-Jun, ATF2 and p53, and to the nonsubstrate transcription factor JunB. For example, JNK's ability to phosphorylate c-jun requires its association with the delta domain, which is positioned within aa 30 ± 57 in the amino terminal region of this protein (Adler et al., 1992) . Indeed, JNK neither binds nor is it capable of phosphorylating v-jun, c-jun's oncogenic counterpart, which lacks the delta domain (Treier et al., 1994) .
Studies by D Bohmann's group have indicated the need for the delta domain, which provides the docking site for trans-signal targeting c-jun for ubiquitination and proteolytic degradation through the proteasome 26S pathway (Treier et al., 1994) . The ®nding that the delta domain is necessary for ubiquitination as well as for JNK binding provided the foundation for the hypothesis that c-jun ubiquitination is targeted by its associated protein, JNK.
That JNK plays an important role in regulating the ubiquitination of c-Jun was con®rmed both in vitro and in vivo (Fuchs et al., 1996; Musti et al., 1997) . JNK does not need to be active as a kinase to target c-jun ubiquitination because phosphorylation mutants (on aa 183, 185) can eciently mediate this targeting activity (Fuchs et al., 1996) . Importantly, JNK targeting of cjun ubiquitination is limited to the unphosphorylated form of the substrate. After JNK phosphorylation of cjun, it can no longer be targeted for ubiquitination, thereby gaining its stability and activity (Fuchs et al., 1996; Musti et al., 1997) .
The knowledge that JNK targets the ubiquitination of c-jun was extended to other JNK-associated proteins. JNK was found to target the ubiquitination of its associated proteins, ATF2 and JunB . ATF2 phosphorylation by JNK renders this protein stable, as JNK can no longer target its ubiquitination, similar to c-jun. Because phosphorylation of ATF2 on aa 69 and 71 could also occur by another stress activated protein kinase, p38, (Raingeard et al., 1996) it is likely that ATF2 gains stability during dierent signaling cascades. Unlike targeting c-jun, ATF2 or Jun-B for ubiquitination, JNK plays no role in the ubiquitination of unassociated ELK1 or JunD . Indeed, Jun-D is signi®cantly more stable than is c-jun .
These observations suggest that JNK association is a prerequisite for targeting of ubiquitination. Phosphorylation of JNK-associated proteins prevent their targeting of ubiquitination through possible changes in their conformation which is expected to abrogate the association of the respective ubiquitin ligase. The emerging model from these observations suggests that JNK, by virtue of its targeting for ubiquitination, is the key regulator of its associated proteins, c-jun, ATF2 and JunB in non-stressed normal growing cells. After stress, JNK's activation by its upstream kinases, followed by phosphorylation of its associated substrates, regulates its stability and activity.
As JNK targets the ubiquitination of its associated proteins, identifying p53 as a JNK-associated protein led to elucidation of the role of JNK in the degradation of this tumor suppressor protein. p53's stability has been shown to be in¯uenced by other cellular proteins including mdm2 (Haupt et al., 1997; Kubbutat et al., 1997) , WT1 (Maheswaran et al., 1995) and hypoxia inducible factor (HIF; An et al., 1998) . While mdm2 was demonstrated to target p53 ubiquitination before its degradation (Honda et al., 1997; Fuchs et al., 1998a) , WT1 and HIF stabilize this tumor suppressor protein (Maheswaran et al., 1995; An et al., 1998) . Mdm2 association with p53 appears to depend on a p53 phosphorylation-dependent conformation and occurs primarily in cells that are grown in nonstressed conditions (Shieh et al., 1997) . In response to external stimuli (e.g, irradiation), changes in p53 phosphorylation occur on amino terminal residues (Hu et al., 1997) that alter p53 conformation and stability (Shieh et al., 1997; Siliciano et al., 1997) . Further insight into the signaling involved in regulation of p53 targeted ubiquitination comes from the observation that activating the JNK signaling pathway via MEKK1 leads to dissociation of MDM2 from p53 which coincides with inhibition of p53 ubiquitination in vivo and prolongs p53 half-life (Fuchs et al., 1998b ). MEKK1's eect on p53 stability could be blocked by inactive JNKK, suggesting that JNK phosphorylation is a determinant of p53 stability. Indeed, deletion of or mutation in the JNK association domain from p53 abrogated MEKK1's ability to aect p53 stability (Fuchs et al., 1998b) . JNK is capable of association with p53 in the non-stressed cells. After UVirradiation of cells, the amount of p53 associated with JNK is signi®cantly decreased despite the robust increase in total p53 level. This inverse correlation suggests that JNK can target p53 degradation in the non-stressed cells. JNK and mdm2 preferentially associate with p53 in dierent phases of cell cycle. JNK-p53 complexes were primarily found in G 0 /G 1 , whereas mdm2-p53 complexes were identi®ed in S/ G 2 M phases. Therefore the mechanism of targeting p53 degradation in non-stressed cells by JNK seems to be mdm2-independent (Fuchs et al., 1998c) .
Another stress-activated kinase that eciently phosphorylates p53 is DNA-PK (Lee-Miller et al., 1992; Wang and Eckhart 1992; Milne et al., 1995) . DNA-PK has been implicated in the phosphorylation of serine 15 at the amino terminal end in response to gamma irradiation (Shieh et al., 1997; Siciliano et al., 1997) . This phosphorylation has been shown to abrogate p53 association with mdm2 resulting in the stabilization of p53 (Shieh et al., 1997) . Moreover, it has been demonstrated that g-irradiation, unlike UVC, stabilizes p53 without abrogation of p53 ubiquitination (Maki and Howley, 1997) . The emerging hypothesis is that phosphorylation of p53 by stress-activated protein kinases (separately or in concert, depending on the types of stress stimuli and cells involved) alters conformation of p53. The acquired p53 conformation no longer allows association with targeting proteins (mdm2, JNK, etc.) resulting in the stabilization and accumulation of p53.
Among cellular components, in addition to JNK and mdm2, that play a role in the regulation of p53 level are WT1 and hypoxia inducible protein, which increase p53 stability. The relationship between these cellular factors and their relative contribution to p53 stability as well as the precise mechanism of targeting are unknown. Regulation of p53 targeting of ubiquitination is dependent upon the availability of its targeting molecules as per expression and proper post-translational modi®cations. That the targeting molecules are subject for ubiquitination further illustrates the complexity of this regulation. For example, mdm2 is targeted for proteasome-dependent degradation by tumor suppressor protein p19 ARF (Pomerantz et al., 1998; Zhang et al., 1998) . Overexpression of p19 ARF resulted in the expected stabilization of p53 and induction of p53-mediated growth arrest and apoptosis. The interplay between mdm2 and other p53 targeting molecules and their implications for p53 function are yet to be determined.
Furthermore, of importance is the well-documented role of viral proteins in p53 stability. The E6 protein of human papilloma virus plays an important role in targeting p53 degradation (Schener et al., 1990) via the E6AP which is among few cellular E3 ubiquitin ligases identi®ed thus far (Schener et al., 1990; Huibergtse et al., 1993) . Conversely, E1B and SV40LT are proteins that stabilize p53 although they also inactivate p53 transactivation (Maheswaran et al., 1995; Oren et al., 1981; Reich et al., 1983) . In infected cells, E1B or SV40LT are expected to prevent p53 association with the cellular proteins that would normally target p53 for ubiquitination, although the nature of the sequestered targeting molecules is yet to be determined. In the same vein, the mechanisms underlying the increased half-life of mutant p53 and potential gain of function mediated by such mutants are still unknown. The interplay between p53 associating proteins before and after stress response is illustrated in Figure 1 . Figure 1 Regulation of p53 ubiquitination before and after stress. Independent association of p53 with its targeting molecules JNK and mdm2 occurs at dierent phases of the cell cycle, and is likely to rely on the conformation/post-translational modi®cation of p53 at each of these cell cycle phases. Phosphorylation of p53 by stress activated kinases, including JNK and DNA-PK results in the dissociation of p53 targeting molecules and prolonged half-life of p53. Being stable and transcriptionally active, p53 exerts its transcriptional activities (as illustrated here with mdm2). Upon the activation of protein phosphatases, p53 could again be targeted for ubiquitination through the association with its targeting molecules, JNK or mdm2
The IkB kinases/IkB -NFkB pathway NFkB is a ubiquitous and inducible transcription factor that activates several cellular genes that encode immunomodulatory cytokines, acute phase proteins and cell-surface receptors. Regulation of NFkB activity is exerted primarily at the level of subcellular localization. In most unstimulated cells, NFkB is sequestered in the cytoplasm in an inactive form by the inhibitor protein IkBa. Sequential phosphorylation, ubiquitination, and degradation of inhibitory protein IkBa leads to activation of the transcription factor NFkB in response to a variety of extracellular signals. It was ®rst demonstrated that proteasome activity is necessary for NFkB activation (Palombella et al., 1994) . Phosphorylation of IkBa at Ser32, 36 was shown to target IkBa for ubiquitination and proteasome-dependent degradation Brown et al., 1995) . Interestingly, this pathway diers from the mechanism of constitutive IkB turnover, which requires the integrity of C-terminal PEST sequences and phosphorylation by casein kinase II (Van Antwerp et al., 1996) . N-terminal phosphorylation of IkB in response to cell stimuli is mediated by IkB kinases (IKKs). IKKs were identi®ed as the components of a large multiprotein complex (Chen et al., 1996; Lee et al., 1997b; and cloned by virtue of interaction with upstream kinase NIK (NFkB-inducing kinase; Regnier et al., 1997) or fractionation of TNFa-inducible kinase activity (DiDonato et al., 1997) . This cDNA happened to be cloned earlier (Connelly and Marcu 1995). It encodes serine-threonine CHUK kinase, which contains multiple protein-protein interaction motifs including a leucine zipper and a helix-loop-helix domain. Renamed IKKa, this kinase was shown to interact with IkB as well as with its putative upstream kinase NIK (Malinin et al., 1997) . The second member of this emerging family was designated IKKb .
It is noteworthy that the 700 kD multi-protein complex puri®ed from unstimulated cells exhibited IkB kinase activity either in the presence of ubiquitination enzymes and ubiquitin or after MEKK1-mediated phosphorylation (Chen et al., 1996; Lee et al., 1997) . Without MEKK1-dependent phosphorylation, the kinase activity requires the ubiquitination of its yet unidenti®ed components (Chen et al., 1996) . This suggests another important role for the ubiquitination system in activating NF-kB pathway.
Both IKKa and IKKb are equally potent in phosphorylating IkB at Ser32,36. This phosphorylation provides the speci®c targeting signal that is recognized by IkB-ubiquitin ligase (Yaron et al., 1997) although the precise identity of IkB-ubiquitin ligase is unknown. The phosphoacceptor sites constituting those recognition signals are conserved between IkBa, IkBb and b-catenin (Aberle et al., 1997; Orford et al., 1997) . Hence, it is possible that GSK3 and IKK phosphorylation may employ the similar E3 complex to mediate targeted ubiquitination of b-catenin and IkB.
Important for inducible IkB ubiquitination are speci®c lysyl residues at aa 21 and 22 which represent the major sites of ubiquitin ligation resulting in multiubiquitination Rodriguez et al., 1996; Baldi et al., 1996) . This mechanism is not similar to the promiscuous use of lysyl residues in c-jun ubiquitination (Treier et al., 1994) .
In addition to regulating the inhibitor (IkB), the ubiquitin-proteasome system is also required for processing the NF-kB precursor protein and, therefore, is directly involved in activation of NF-kB (Palombella et al., 1994; Sears et al., 1998 ).
An equally important component in signal transduction-mediated protein stability is the availability and activity of speci®c phosphatases. Calyculin A, an inhibitor of serine/threonine phosphatase induces rapid degradation of IkBb due to its hyper phosphorylation (Harhaj and Sun 1997; Menon et al., 1995) . On the same line, activation of NFkB by phosphatase inhibitors involves the phosphorylation of IkB at phosphatase 2A-sensitive sites (Sun et al., 1995) .
GSK3 and beta catenin
Classical cadherins are complexed through their cytoplasmic domains with three major catenins. Beta-catenin plays a central role in the architecture of the cadherin-catenin complex, linking cadherins to alpha catenin, which in turn mediates the anchorage of the cadherin complex to the cortical actin cytoskeleton. In addition, these proteins might also be involved in the signaling pathway initiated by Wnt proteins, mediators of several developmental processes. It is believed that dierent pools of b-catenin (cytosolic versus membrane-bound) contribute to those dierent functions. Currently available data strongly suggest that accumulated cytosolic b-catenin exhibits oncogenic properties. Overexpression and translocation of b-catenin to nuclei upregulates Tcf/ Lef transcription factors and induces serum-independent cellular proliferation (Young et al., 1998) . Therefore, control of b-catenin stability is central in regulating its activities. Regulation of b-catenin turnover is mediated by phosphorylation by glycogen synthase kinase-3 (GSK-3) which triggers the ubiquitination of b-catenin (Aberle et al., 1997; Orford et al., 1997) . Numerous associated proteins that aect the phosphorylation, ubiquitination and stability of bcatenin have been identi®ed (Su et al., 1993) . One principal regulator of b-catenin level is the product of the APC (adenomatous polyposis coli) tumor supressor gene (Su et al., 1993; Rubinfeld et al., 1996) . Overexpression of APC decreases the level of bcatenin (Munemitsu et al., 1995) and blocks cell-cycle progression. APC frequent mutation in colon cancers impairs its targeting of b-catenin for ubiquitination, resulting in b-catenin accumulation (Munemitsu et al., 1995) . The ability of APC to target b-catenin for degradation depends on the integrity of b-catenin phosphoacceptor sites. The emerging hypothesis suggests that APC participates in targeting b-catenin for ubiquitination in a phosphorylation-dependent manner with other proteins (eg, axin, conductin; Behrens et al., 1998; Sakanaka et al., 1998) , although the precise mechanisms of phosphorylation and ubiquitination of b-catenin are yet to be determined. Importantly, stabilizing mutations in b-catenin and in the components regulating its stability have been implicated in colon cancer and malignant melanomas (Rubinfeld et al., 1997; Morin et al., 1997) .
JAK-STAT signaling
Many cytokines, hormones, and growth factors signal their target cells through the JAK-STAT signal transduction pathway. This pathway involves activating signal transducers and activators of transcription (STATs). STATs are rapidly activated via tyrosine phosphorylation by Janus kinase (JAK) family members. Phosphorylation of STAT1 transcription factor by JAK in response to gamma-interferon leads to the translocation of STAT1 into the nucleus followed by binding to GAS motifs and activation of speci®c transcription. However, phosphorylated STATs are subsequently inactivated within a short period as the same phosphorylation targets STAT1 for ubiquitination and subsequent proteasome-dependent degradation (Kim and Maniatis, 1996) . Therefore, activated by JAK-mediated phosphorylation, STAT1 exhibits its transcriptional activities within a time frame that is stringently regulated by ubiquitination.
Stimulation by interleukin 3 in the presence of proteasome inhibitors led to stable phosphorylation and prolonged activation of JAK2 and JAK1 suggesting that proteasome-mediated protein degradation can modulate the activity of the JAK/STAT pathway by regulating the deactivation of JAK. The eect of proteasome inhibitors was not restricted to the JAK/STAT pathway, as Shc and mitogen-activated protein kinase (MAPK) phosphorylation were also prolonged (Callus and Mathey-Prevot, 1998) .
The alteration of ubiquitination-dependent inactivation of JAK/STAT pathways is likely to have important biological consequences. For instance, phosphorylation and DNA-binding activity of STAT1 was signi®cantly shorter in lymphoma cells resistant to growth inhibition by interferon as compared with their isogenic sensitive counterparts (Grimley et al., 1998) .
Protein kinase C (PKC)
Protein kinase C comprises a family of at least nine distinct isoforms some of which are responsive to the tumor promoting phorbol esters. While PKC isozymes elicit dierent biological functions, many of them are regulated through the ubiquitin-proteasome system. Phorbol esters are long known to activate responsive PKC isoforms, although, after prolonged treatment, these isoforms are proteolytically degraded (Nishizuka, 1995) . The correlation between PKC activation by bryostatin and attachment of ubiquitin to PKC (Lee et al., 1996) suggested that, after prolonged treatment, bryostatins and phorbol esters down-regulate by inducing its proteolysis. Inhibition of proteasome function by lactacystin preserved the PKC activity in vivo, as shown by the retention of bryostatin-induced autophosphorylation of PKC-a. (Lee et al., 1997a) . Lastly, the direct evidence linking PKC activation with its ubiquitination and degradation was obtained (Lu et al., 1998) . Although the detailed mechanism is unknown, clearly, the PKC catalytic activity per se is indispensable for its ubiquitination. Importantly, this mechanism provides an explanation for down-regulation of PKC activity after chronic treatment with phorbol esters. This, in turn, suggest that downregulation of PKC activity by ubiquitination and degradation may be instrumental in the mechanism of tumor promotion by phorbol esters (Lu et al., 1998) . Regulation of PKC stability by speci®c phosphatases was shown to have an inverse correlation to its cellular localization and activity (Seedorf et al., 1995) .
C-Kit
C-kit is an example of a receptor tyrosine kinase that triggers its own ubiquitination and degradation after activation. Ubiquitination of Kit receptor, which plays an important role in hematopoiesis and melanogenesis, was observed after Kit ligand-mediated activation and was absent when a kinase-dead mutant was studied. Accordingly, the degradation of kinase-inactive Kit receptor complexes is known to be substantially impaired as compared with its wild-type counterpart. Therefore, as for PKC, c-Kit ubiquitination and subsequent degradation require an active kinase (Yee et al., 1994) .
Mos/MAPK pathway
The c-mos proto-oncogene product is a serine/threonine kinase that is directly phosphorylated by the MAPK/ ERK kinase (MEK) and, as a result, activates mitogenactivated protein kinases (ERK1-2) in response to a variety of mitogenic signals in the germline cells (Nebreda et al., 1993) . ERK activation was shown to be required for the oncogenic transformation of mouse ®broblasts by Mos (Okazaki and Sagata, 1995) . Mosinduced phosphorylation of c-Fos on its C-terminal region (Ser362 and 374; Barber and Verma, 1987) leads to the stabilization of c-Fos protein (Okazaki and Sagato, 1995) . Replacement of both serines with Asp (to mimic phosphorylation) markedly increased the stability and transforming eciency of c-fos, even in the absence of mos. Through phosphorylation-mediated stabilization of c-fos, Mos resembles the JNK pathway in which phosphorylation protects the substrate from ubiquitination and prolongs its half-life. Interestingly, C-mos itself is degraded via ubiquitin-proteasome pathway soon after the Mos-dependent signal is transduced in Xenopus oocytes. Dephosphorylation of Ser3 by unknown phosphatase is absolutely required for Mos ubiquitination and degradation (Nishizawa et al., 1993) .
Epilogue
Among multiple mechanisms that determine the halflives of active molecules, the targeting of proteins for ubiquitination appears to be a dynamic process that is closely regulated by post-translational modi®cations, as summarized in Figure 2 . Although current knowledge allows us to understand the role of protein kinases, equally important is to elucidate the contribution of protein phosphatases, which are thought to balance protein phosphorylation in a cell cycle, and stress related manner. The contribution of protein phosphatases to overall protein phosphorylation and thus targeted ubiquitination may be modulated in tumor cells in which activity of speci®c phosphatases has been altered. The characterization of speci®c phosphatases for each of the kinases discussed in this review is crucial for our ability to understand the nature of this regulation. Protein phosphatases themselves may be regulated by degradation as the PEST motif is commonly contained in their sequences.
The regulation of protein targeting for ubiquitination dictates the duration and magnitude of a protein's ability to perform its cellular function; our current understanding provides new opportunities for insight into key cellular regulatory processes in normal growing, stressed, and transformed cells. This regulation is thought to occur at the levels of posttranslational state (i.e., conformation) of the proteins and their association with other cellular or viral proteins. This process can be dramatically altered by activating or inactivating mutations present in human cancer. Evidence for the changes in targeting of mutant protein ubiquitination are seen in the examples of p53 and b-catenin as a substrate and of APC as a targeting molecule. Possibly, the altered stability of tumor suppressor proteins convey a functional gain as was recently demonstrated for mutant p53' ability to transactivate new promoters, which were not seen with the wild-type protein. Finally, understanding the mechanisms by which proteins are targeted for ubiquitination is expected to assist in the design of a new class of modulators for targeting ubiquitination of speci®c cellular regulatory proteins. 
